Breakthrough trial tests two new injectables to stop strokes in High-Risk heart patients
NCT ID NCT07430956
First seen Feb 25, 2026 · Last updated Apr 20, 2026 · Updated 7 times
Summary
This large, late-stage study is testing two new injectable drugs, REGN7508 and REGN9933, to prevent strokes and blood clots in people with an irregular heartbeat called atrial fibrillation. The study is specifically for people who cannot or choose not to take standard oral blood thinners. Researchers will compare the new drugs against a placebo to see which is safer and more effective at preventing strokes without causing serious bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.